Kejing Ying

Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer

Ying Cheng, Liang Han, Lin Wu et al. · JAMA · 2022 · 456 citations · Full text

Medicine, Oncology, Pharmacology +17

Tislelizumab Plus Chemotherapy vs Chemotherapy Alone as First-line Treatment for Advanced Squamous Non–Small-Cell Lung Cancer

Jie Wang, Shun Lü, Xinmin Yu et al. · JAMA Oncology · 2021 · 398 citations · Full text

Medicine, Oncology, Pharmacology +16

The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines

Yishan Wang, Yanjie Hu, Di Wang et al. · Cancer Biomarkers · 2012 · 161 citations · Full text

Pharmacy, Toxicology, Analytical Toxicology +11

METTL3 promotes lung adenocarcinoma tumor growth and inhibits ferroptosis by stabilizing SLC7A11 m6A modification

Yiming Xu, Dandan Lv, Chao Yan et al. · Cancer Cell International · 2022 · 159 citations · Full text

Medicine, Cancer Biology, Oncology +17

Trends in Hospitalization and In-Hospital Mortality From VTE, 2007 to 2016, in China

Zhu Zhang, Jieping Lei, Shao Xiang et al. · CHEST Journal · 2018 · 158 citations

Medicine, Health Sciences, Internal Medicine +12